Additionally, the dendritic cell-like biomimetic nanoparticles enhanced IFN-γ and TNF-α expression by naive T lymphocytes and exhibited superior therapeutic outcomes in reducing tumor growth [53]. The gene discussed is TNF; the disease is neoplasm.